Aqneursa Granule, For Suspension
Product Images NDC 83853-101

13 FDA label images from Intrabio Inc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Aqneursa (NDC 83853-101). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Intrabio Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2-acetamido-4-methylpentanoic Acid (Image 01)

2-acetamido-4-methylpentanoic Acid (Image 01)
Chemical structure of levacetylleucine, the active ingredient in AQNEURSA. The diagram shows the molecular arrangement of atoms including a six-membered ring, hydroxyl group, amide, and methyl groups.*
FDA Label Image

Mean (+/- Standard Error) Plot Of The Fsara Total Score By Time And Treatment Sequence (Image 02)

Mean (+/- Standard Error) Plot Of The Fsara Total Score By Time And Treatment Sequence (Image 02)
Line graph comparing the fSARA Total Score over time (Baseline to 24 Weeks) between AQNEURSA treatment and placebo groups. The x-axis represents timepoints (Baseline, 6, 12, 18, 24 Weeks) and the y-axis shows fSARA Total Score from 4.0 to 7.0. AQNEURSA shows a gradual decline, while placebo initially decreases then increases. Error bars indicate variability at each point.*
FDA Label Image

Mean (+/- Standard Error) Plot Of The Sara Total Score By Time And Treatment Sequence (Image 03)

Mean (+/- Standard Error) Plot Of The Sara Total Score By Time And Treatment Sequence (Image 03)
A line graph comparing SARA Total Scores across Visits 2 to 6 for two treatments: IB1001 and Placebo. The solid line represents IB1001 showing a decreasing trend in scores over visits, while the dashed line for Placebo remains relatively stable. Error bars indicate variability for each data point.*
FDA Label Image

Empty The Entire Contents Of 1 Aqneursa Packet Into A Container With 40 mL Water (Image 04)

Empty The Entire Contents Of 1 Aqneursa Packet Into A Container With 40 mL Water (Image 04)
An instructional line drawing showing a hand pouring granules from a small packet into a glass of liquid, illustrating preparation of a suspension dose.*
FDA Label Image

Stir To Form The Suspension (Image 05)

Stir To Form The Suspension (Image 05)
An instructional line drawing showing a hand stirring a spoon in a glass filled with liquid. This illustration likely demonstrates preparation or mixing of an oral suspension, such as AQNEURSA levacetylleucine granules for suspension.*
FDA Label Image

Swallow Aqneursa Oral Suspension Right Away (Image 06)

Swallow Aqneursa Oral Suspension Right Away (Image 06)
Line art illustration showing a person drinking from a clear glass containing a granulated or suspended liquid. The image suggests oral consumption of a suspension dosage form, consistent with granules for suspension such as AQNEURSA (levacetylleucine).*
FDA Label Image

Draw Up The Prepared Aqneursa Oral Suspension Into A Catheter Tip Syringe (Image 07)

Draw Up The Prepared Aqneursa Oral Suspension Into A Catheter Tip Syringe (Image 07)
Instructional line drawing showing hands using a syringe-like device to extract liquid from a cup. The top hand pulls the plunger upward, while the bottom hand holds the barrel steady, with liquid being drawn into the device. This illustration demonstrates the proper method for drawing up liquid, likely for oral suspension administration.*
FDA Label Image

Inject The Aqneursa Oral Suspension Through The G-tube Right Away (Image 08)

Inject The Aqneursa Oral Suspension Through The G-tube Right Away (Image 08)
An instructional line drawing showing two hands using an oral syringe to withdraw or administer medication from a tube or bottle. The right hand is pulling the plunger of the syringe outward, indicated by a directional arrow, while the left hand holds the connected tube. The illustration demonstrates proper technique for measuring or dispensing liquid medication orally.*
FDA Label Image

Refill The Syringe With An Additional 20 mL Water (Image 09)

Refill The Syringe With An Additional 20 mL Water (Image 09)
An instructional illustration showing hands preparing an oral suspension using a syringe-like measuring device. One hand holds the syringe while the other hand depresses the plunger to draw liquid from a container below, demonstrating measuring or dispensing a dose of medication.*
FDA Label Image

Flush The G-tube With Water (Image 10)

Flush The G-tube With Water (Image 10)
An instructional line drawing showing hands administering oral medication using a syringe attached to a feeding tube. The illustration highlights the proper technique for delivering liquid medication through the tube with a plunger being pressed, indicated by an arrow.*
FDA Label Image

Aqneursa Carton (Image 11)

Aqneursa Carton (Image 11)
The packaging label for AQNEURSA (levacetylleucine) 1000 mg granule for oral suspension by IntraBio Inc displays the product name and strength prominently. It indicates a 1 gram per packet dosage with 28 unit-dose packets per box. The label includes directions for use, storage conditions, and a barcode, along with the labeler's location in Austin, TX.*
FDA Label Image

Aqneursa Packet Front (Image 12)

Aqneursa Packet Front (Image 12)
Label for AQNEURSA (levacetylleucine) granule for oral suspension, showing 1 gram per packet strength. The label includes dosing directions advising to see enclosed instructions and use within 30 minutes. It is a single unit-dose packet labeled for prescription use only by IntraBio Inc with NDC 83853-101-01.*
FDA Label Image

Aqneursa Packet Back (Image 13)

Aqneursa Packet Back (Image 13)
Label for AQNEURSA granule for suspension containing 1000 mg levacetylleucine per unit-dose packet. It states each packet contains 1 gram of levacetylleucine and inactive ingredients hypromellose, isomalt, and strawberry flavor. The label includes storage instructions, manufacturer IntraBio Inc, Austin, TX, product origin Austria, lot and expiration fields, and barcode with product NDC 83853-101.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.